{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:11:42Z","timestamp":1788970302880,"version":"build-2803163510"},"reference-count":31,"publisher":"The Journal of Health Economics and Outcomes Research","issue":"2","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["jheor.org"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec id=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multitarget stool DNA (mt-sDNA) testing is an established noninvasive colorectal cancer (CRC) screening option for average-risk adults, but real-world completion of the screening cascade through colonoscopy remains incompletely characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"objectives\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to evaluate mt-sDNA adherence, test positivity, and follow-up colonoscopy completion in a regional healthcare system and identify factors associated with screening cascade completion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study analyzed mt-sDNA test kits ordered for average\u2011risk, screening\u2011eligible individuals in the Spartanburg Regional Healthcare System (South Carolina, USA) from January 2016 to June 2023. Analyses were conducted at the test-kit level; patients could contribute more than one eligible test during the study period. Eligible tests were from patients aged 45 to 85 years with \u22656 months of prior continuous insurance coverage and no high-risk CRC conditions. Outcomes were adherence (kit return within 365 days), test positivity among adherent test kits, and follow\u2011up colonoscopy within 365 days among eligible positive cases. Multivariable logistic regression and Cox proportional hazards regression models evaluated factors associated with adherence and time to colonoscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 8439 included test kits, 5733 (67.9%) were returned within 1 year. Among returned test kits, 1018 (17.8%) yielded a positive mt-sDNA result. Of 853 positive tests eligible for follow-up assessment, 596 (69.9%) were for patients who completed follow-up colonoscopy. Adherence to mt-sDNA testing was associated with non-Medicaid insurance, higher income, digital outreach, prior test return, and lower comorbidity burden. Time to colonoscopy was shorter for patients in the middle vs lowest income group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"discussion\">\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Medicaid insurance was the strongest insurance-related predictor of nonadherence, with rates approximately 20 percentage points below those with commercial or Medicare-type coverage. Digital outreach and prior test return history were among the independent predictors of adherence. Income was the primary independent predictor of time to follow-up colonoscopy, potentially reflecting financial barriers to diagnostic follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this real-world cohort study, approximately two-thirds of tests were returned and 70% of eligible positive tests completed follow-up colonoscopy within 1 year. These findings identify potentially modifiable socioeconomic and outreach-related factors associated with screening cascade completion and support targeted interventions for lower-income and Medicaid-insured populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.36469\/001c.168717","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:24:43Z","timestamp":1788967483000},"update-policy":"https:\/\/doi.org\/10.36469\/00001","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Adherence and Follow-Up Colonoscopy After Multitarget Stool DNA Screening in a Regional Healthcare System"],"prefix":"10.36469","volume":"13","author":[{"given":"Amanda","family":"Hanson","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03v25yt44","id-type":"ROR","asserted-by":"publisher"}],"name":"Spartanburg Regional Healthcare System","department":["Precision Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrey","family":"Gohil","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0525bj441","id-type":"ROR","asserted-by":"publisher"}],"name":"Abbott","department":["Medical Affairs"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Abdelmoity","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03v25yt44","id-type":"ROR","asserted-by":"publisher"}],"name":"Spartanburg Regional Healthcare System","department":["Precision Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Omar","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0525bj441","id-type":"ROR","asserted-by":"publisher"}],"name":"Abbott","department":["Medical Affairs"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kazberuk","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0525bj441","id-type":"ROR","asserted-by":"publisher"}],"name":"Abbott","department":["Medical Affairs"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Karlitz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0525bj441","id-type":"ROR","asserted-by":"publisher"}],"name":"Abbott","department":["Medical Affairs"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallik","family":"Greene","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0525bj441","id-type":"ROR","asserted-by":"publisher"}],"name":"Abbott","department":["Medical Affairs"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22273","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"101202","DOI":"10.1016\/j.pmedr.2020.101202","article-title":"Colorectal cancer screening completion: an examination of differences by screening modality","volume":"20","author":"L. J. Finney Rutten","year":"2020","journal-title":"Prev Med Rep"},{"issue":"3","key":"ref2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/03007995.2024.2303090","article-title":"Colorectal cancer screening uptake and adherence by modality at a large tertiary care center in the United States: a retrospective analysis","volume":"40","author":"C. Cheney","year":"2024","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"ref3","doi-asserted-by":"publisher","first-page":"e2251384","DOI":"10.1001\/jamanetworkopen.2022.51384","article-title":"Rates of Follow-up colonoscopy after a positive stool-based screening test result for colorectal cancer among health care organizations in the US, 2017-2020","volume":"6","author":"J. T. Mohl","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"ref4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3322\/caac.21615","article-title":"Mailed fecal immunochemical test outreach for colorectal cancer screening: summary of a Centers for Disease Control and Prevention\u2013sponsored summit","volume":"70","author":"S. Gupta","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"ref5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/1940-6207.Capr-21-0075","article-title":"Impact of patient adherence to stool-based colorectal cancer screening and colonoscopy following a positive test on clinical outcomes","volume":"14","author":"A. M. Fendrick","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"ref6","doi-asserted-by":"publisher","first-page":"e242693","DOI":"10.1001\/jamanetworkopen.2024.2693","article-title":"Development of a follow-up measure to ensure complete screening for colorectal cancer","volume":"7","author":"E. L. Ciemins","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"ref7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/03007995.2022.2116172","article-title":"Patterns of initial colorectal cancer screenings after turning 50 years old and follow-up rates of colonoscopy after positive stool-based testing among the average-risk population","volume":"39","author":"G. Austin","year":"2023","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"ref8","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1080\/03007995.2025.2573654","article-title":"Closing the loop in colorectal cancer screening: real-world adherence to follow-up colonoscopy after positive mt-sDNA vs FIT\/FOBT, stratified by payer type","volume":"41","author":"M. Greene","year":"2025","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"ref9","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/1055-9965.Epi-13-1217","article-title":"The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium","volume":"23","author":"J. A. Tiro","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"40","key":"ref10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/jncimonographs\/lgq008","article-title":"Organizational factors and the cancer screening process","volume":"2010","author":"R. Anhang Price","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","first-page":"e70043","DOI":"10.3322\/caac.70043","article-title":"Cancer statistics, 2026","volume":"76","author":"R. L. Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"ref12","doi-asserted-by":"publisher","first-page":"e245295","DOI":"10.1001\/jamanetworkopen.2024.5295","article-title":"Colorectal cancer screening after sequential outreach components in a demographically diverse cohort","volume":"7","author":"C. Podmore","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"10","key":"ref13","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1080\/03007995.2025.2589536","article-title":"Adherence to multi-target stool DNA test and time to follow-up colonoscopy: real-world analysis of patients from the Beth Israel Lahey Health","volume":"41","author":"M. Greene","year":"2025","journal-title":"Curr Med Res Opin"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03007995.2025.2591406","article-title":"Adherence to multi-target stool DNA screening and timeliness of follow-up colonoscopy: a real-world study from Tufts Medical Center","author":"M. Greene","year":"2025","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"ref15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s00384-025-04997-5","article-title":"Adherence to multi-target stool DNA colorectal cancer screening and clinical follow-up in the Hartford HealthCare system","volume":"40","author":"S. Gohil","year":"2025","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"ref16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.amepre.2019.09.015","article-title":"Initiation of colorectal cancer screening among Medicaid enrollees","volume":"58","author":"C. M. Mojica","year":"2020","journal-title":"Am J Prev Med"},{"issue":"10","key":"ref17","doi-asserted-by":"publisher","first-page":"e2437492","DOI":"10.1001\/jamanetworkopen.2024.37492","article-title":"Social risk factor domains and preventive care services in US adults","volume":"7","author":"T. Schroeder","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"7","key":"ref18","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1007\/s11606-020-06415-8","article-title":"Text messaging and opt-out mailed outreach in colorectal cancer screening: a randomized clinical trial","volume":"36","author":"S. W. Huf","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"1","key":"ref19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.36469\/001c.133939","article-title":"Impact of digital navigation on screening adherence with the multi-target stool DNA test","volume":"12","author":"M. Greene","year":"2025","journal-title":"J Health Econ Outcomes Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"10732748251343334","DOI":"10.1177\/10732748251343334","article-title":"Impact of Spanish language outreach on multi-target stool DNA test adherence in a Federally Qualified Health Center in the United States","volume":"32","author":"M. Greene","year":"2025","journal-title":"Cancer Control"},{"issue":"9","key":"ref21","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.cgh.2022.12.026","article-title":"Multitarget stool DNA testing has high positive predictive value for colorectal neoplasia on the second round of testing","volume":"21","author":"J. K. Voss","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"ref22","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.14309\/ajg.0000000000003198","article-title":"Disparities, trends, and predictions to 2040 in gastrointestinal cancer incidence, mortality in the United States","volume":"120","author":"Y. Huang","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"ref23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1053\/j.gastro.2022.05.036","article-title":"Age-stratified prevalence and predictors of neoplasia among U.S. adults undergoing screening colonoscopy in a national endoscopy registry","volume":"163","author":"P. S. Liang","year":"2022","journal-title":"Gastroenterology"},{"issue":"10","key":"ref24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1158\/1940-6207.Capr-22-0153","article-title":"Cost-effectiveness of waiving coinsurance for follow-up colonoscopy after a positive stool-based colorectal screening test in a Medicare population","volume":"15","author":"A. M. Fendrick","year":"2022","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"ref25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10620-015-3600-5","article-title":"The impact of screening on colorectal cancer mortality and incidence: has it really made a difference?","volume":"60","author":"A. G. Zauber","year":"2015","journal-title":"Dig Dis Sci"},{"key":"ref26","article-title":"Increase the proportion of adults who get screened for colorectal cancer","author":"US Department of Health and Human Services. Office of Disease Prevention and Health Promotion"},{"key":"ref27","article-title":"Achieving 80% colorectal cancer screening rates in every community","author":"American Cancer Society National Colorectal Cancer Roundtable"},{"issue":"19","key":"ref28","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","article-title":"Screening for colorectal cancer: US preventive services task force recommendation statement","volume":"325","author":"US Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"issue":"14","key":"ref29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"T. F. Imperiale","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"ref30","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.14309\/ajg.0000000000000445","article-title":"Multitarget stool DNA Test performance in an average-risk colorectal cancer screening population","volume":"114","author":"L. J. W. Bosch","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"ref31","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1056\/NEJMoa2310336","article-title":"Next-generation multitarget stool DNA test for colorectal cancer screening","volume":"390","author":"T. F. Imperiale","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Journal of Health Economics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jheor.org\/article\/168717-real-world-adherence-and-follow-up-colonoscopy-after-multitarget-stool-dna-screening-in-a-regional-healthcare-system","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:24:44Z","timestamp":1788967484000},"score":1,"resource":{"primary":{"URL":"https:\/\/jheor.org\/article\/168717-real-world-adherence-and-follow-up-colonoscopy-after-multitarget-stool-dna-screening-in-a-regional-healthcare-system"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.36469\/001c.168717","relation":{},"ISSN":["2327-2236"],"issn-type":[{"value":"2327-2236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}